vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $80.1M, roughly 1.0× AMERISAFE INC). AMERISAFE INC runs the higher net margin — 10.2% vs -38.1%, a 48.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 10.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 2.8%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
AMSF vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $83.1M |
| Net Profit | $8.1M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 10.2% | -38.1% |
| Revenue YoY | 10.3% | 20.2% |
| Net Profit YoY | -9.0% | -27.9% |
| EPS (diluted) | $0.43 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | $83.1M | ||
| Q4 25 | $81.6M | $76.4M | ||
| Q3 25 | $82.0M | $83.3M | ||
| Q2 25 | $81.1M | $79.2M | ||
| Q1 25 | $72.6M | $69.2M | ||
| Q4 24 | $74.0M | $68.2M | ||
| Q3 24 | $78.7M | $58.4M | ||
| Q2 24 | $75.8M | $53.4M |
| Q1 26 | $8.1M | $-31.6M | ||
| Q4 25 | $10.4M | $-29.8M | ||
| Q3 25 | $13.8M | $-21.4M | ||
| Q2 25 | $14.0M | $-19.6M | ||
| Q1 25 | $8.9M | $-24.7M | ||
| Q4 24 | $13.2M | $-18.9M | ||
| Q3 24 | $14.3M | $-21.0M | ||
| Q2 24 | $11.0M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 15.6% | -40.6% | ||
| Q3 25 | 21.3% | -27.8% | ||
| Q2 25 | 21.5% | -28.0% | ||
| Q1 25 | 15.5% | -39.7% | ||
| Q4 24 | 22.7% | -28.9% | ||
| Q3 24 | 22.6% | -38.4% | ||
| Q2 24 | 18.1% | -50.3% |
| Q1 26 | 10.2% | -38.1% | ||
| Q4 25 | 12.8% | -39.1% | ||
| Q3 25 | 16.9% | -25.7% | ||
| Q2 25 | 17.2% | -24.7% | ||
| Q1 25 | 12.3% | -35.8% | ||
| Q4 24 | 17.8% | -27.6% | ||
| Q3 24 | 18.2% | -35.9% | ||
| Q2 24 | 14.5% | -48.0% |
| Q1 26 | $0.43 | $-0.56 | ||
| Q4 25 | $0.55 | $-0.54 | ||
| Q3 25 | $0.72 | $-0.38 | ||
| Q2 25 | $0.73 | $-0.35 | ||
| Q1 25 | $0.47 | $-0.45 | ||
| Q4 24 | $0.69 | $-0.34 | ||
| Q3 24 | $0.75 | $-0.40 | ||
| Q2 24 | $0.57 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $246.6M | $347.7M |
| Total Assets | — | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | $245.6M | ||
| Q4 25 | $61.9M | $286.5M | ||
| Q3 25 | $54.7M | $294.3M | ||
| Q2 25 | $48.5M | $302.7M | ||
| Q1 25 | $44.8M | $316.2M | ||
| Q4 24 | $44.1M | $333.7M | ||
| Q3 24 | $63.7M | $196.8M | ||
| Q2 24 | $30.6M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $246.6M | $347.7M | ||
| Q4 25 | $251.6M | $365.9M | ||
| Q3 25 | $274.8M | $380.3M | ||
| Q2 25 | $265.6M | $385.8M | ||
| Q1 25 | $260.8M | $389.2M | ||
| Q4 24 | $257.3M | $402.2M | ||
| Q3 24 | $314.4M | $241.2M | ||
| Q2 24 | $301.0M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $1.1B | $508.1M | ||
| Q3 25 | $1.2B | $511.5M | ||
| Q2 25 | $1.2B | $513.1M | ||
| Q1 25 | $1.2B | $519.4M | ||
| Q4 24 | $1.2B | $534.0M | ||
| Q3 24 | $1.3B | $374.1M | ||
| Q2 24 | $1.2B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSF
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
